Abstract
It has been shown in humans that both alpha2-adrenoceptor activation by clonidine (CLON) and cholinergic enhancement by pyridostigmine (PD) have a clear-cut stimulatory effect on GH release. As this effect is probably mediated by two different mechanisms, i.e. via increased endogenous GHRH for CLON and via inhibition of endogenous somatostatin for PD, in 8 normal children we studied the effect of both single and combined acute oral administration of CLON (150 μg/m2) and PD (60 mg). When administered alone, CLON and PD induced a similar GH increase (peak, mean ±SE: 14.6 ± 2.4 vs 14.2 ± 3.1 ng/ml; area under curve, AUC: 376.9 ± 57.6 vs 390.0 ± 74.3 ng/ml/h). Combined administration of CLON and PD had an additive effect on GH release (peak: 27.5 ± 4.5 ng/ml; AUC: 920.8 ± 153.3 ng/ml/h; p < 0.005 vs CLON and PD alone). In conclusion, presented data show that: i) CLON and PD have similar GH-releasing effect in normal children; ii) The additive stimulatory effect on GH release exerted by acute combined administration of CLON and PD agrees with the hypothesized different mechanism of action of these two drugs; iii) A therapeutic association of CLON and PD may be envisaged in the treatment of some children of short stature.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Müller E.E. Neural control of somatotrophic function. Physiol. Rev. 67:962, 1987.
Lal S., Tolis G., Martin J.B., Brown G.M., Guyda H. Effect of clonidine on growth hormone, luteinizing hormone, follicle stimulating hormone and thyroid stimulating hormone in the serum of normal men. J. Clin. Endocrinol. Metab. 41: 703, 1975.
Massara F., Ghigo E., Demislis K., Tangolo D., Mazza E., Locatelli V., Müller E.E., Molinatti G.M., Camanni F. Cholinergic involvement in the growth hormone releasing hormone-induced growth hormone release. Studies in normal and acromegalic subjects. Neuroendocrinology 43: 670, 1986.
Eden S., Eriksson E., Marin J.B. Evidence for a growth hormone releasing factor mediating alpha adrenergic influence on growth hormone secretion in the rat. Neuroendocrinology 33: 24, 1981.
Miki N., Ono M., Shizume K. Evidence that opiatergic and alpha adrenergic mechanism stimulate rat growth hormone release via growth hormone releasing factor. Endocrinology 114:1950, 1984.
Katakami H., Kato Y., Murakami Y., Tanaka H., Imura H. Stimulation by alpha adrenergic mechanism in growth hormone release induced by opioid peptides in conscious rats. Neuroendocrinology 33:129, 1986.
Kabayama Y., Kato Y., Murakami Y., Tanaka H., Imura H. Stimulation by alpha adrenergic mechanism on the secretion of growth hormone-releasing factor (GRF) from perfused rat hypothalamus. Endocrinology 119: 432, 1986.
Cella S.G., Locatelli V., De Gennaro V., Pellini C., Pintor C., Müller E.E. In vivo studies with GH-releasing factor and clonidine in rat pups: ontogenetic development of their effect on GH release and synthesis. Endocrinology 119:1164, 1986.
Chihara K., Arimura A., Shally A.V. Effect of intraventricular injection of dopamine, norepinephrine, acetylcholine, and 5-hydroxytryptamine on immunoreactive somatostatin release into rat portal blood. Endocrinology 104:1656, 1979.
Richardson S.B., Hollander G.S., D’Eletto S.D., Greenleaf P.W., Than C. Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro. Endocrinology 107:1837, 1980.
Locatelli V., Torsello A., Redaelli M., Ghigo E., Massara F., Müller E.E. Cholinergic agonists and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin. J. Endocrinol.111: 271, 1986.
Tanner J.M., Whitehouse R.H., Marshall W.A., Healy M.S.R., Goldstein H. Assessment of skeletal maturity and prediction of adult height. Academic Press, New York, 1975.
Tanner J.M., Whitehouse R.H. Clinical longitudinal standards for height, weight, height velocity, weight velocity and stages of puberty. Arch. Dis. Child. 51:170, 1976.
Plotsky P., Vale W. Patterns of growth hormone-releasing factor and somatostatin secretion into the hypophysial portal circulation of the rat. Science 230: 461, 1985.
Massara F., Ghigo E., Molinatti P., Mazza E., Locatelli V., Müller E.E., Camanni F. Potentation of cholinergic tone by pyridostigmine bromide reinstates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. Acta Endocrinol. (Kbh.) 113: 12, 1986.
Ghigo E., Mazza E., Imperiale E., Rizzi G., Benso L., Müller E.E., Camanni F., Massara F. The enhancement of cholinergic tone by pyridostigmine promotes both basal and growth-hormone (GH)-releasing hormone-induced GH secretion in children of short stature. J. Clin. Endocrinol. Metab. 65: 452, 1987.
Gil-Ad I., Topper E., Laron Z. Oral clonidine as a growth hormone stimulation test. Lancet 2: 278, 1978.
Pintor C., Cella S.G., Corda R., Locatelli V., Puggioni R., Loche S., Müller E.E. Clonidine accelerates growth in children with impaired growth hormone secretion. Lancet 1: 1482, 1985.
Pintor C., Cella S.G., Loche S., Puggioni R., Corda R., Locatelli V., Müller E.E. Clonidine treatment for short stature. Lancet 1:1226, 1987.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ghigo, E., Goffi, S., Mazza, E. et al. Acute administration of pyridostigmine and clonidine has an additive stimulatory effect on GH release in normal children. J Endocrinol Invest 12, 99–101 (1989). https://doi.org/10.1007/BF03349930
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349930